Evaluating the CUE1 device for older adults with Parkinson's Disease
Useability and Acceptability of the CUE1 Device in Older People With Parkinson's Disease
This study is testing a new wearable device to see if it can help older adults with Parkinson's Disease manage their motor symptoms and if they find it easy to use.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 20 (estimated) |
| Ages | 60 Years to 100 Years |
| Sex | All |
| Sponsor | Cambridge University Hospitals NHS Foundation Trust Academic / other |
| Locations | 1 site (Cambridge) |
| Trial ID | NCT06430151 on ClinicalTrials.gov |
What this trial studies
This study assesses the usability and acceptability of the CUE1 device, a non-invasive wearable technology designed to help manage motor symptoms in older adults with Parkinson's Disease. Participants aged over 60 will undergo initial assessments of their motor symptoms and quality of life, followed by the fitting of the CUE1 device. After 20 minutes of use, repeat assessments will be conducted, and participants will maintain a daily diary regarding their experience with the device over a four-week period. The goal is to determine if the device is practical and well-received by this population.
Who should consider this trial
Good fit: Ideal candidates are individuals over 60 years old with a clinical diagnosis of Parkinson's Disease under the care of a movement disorder service.
Not a fit: Patients with significant co-existing neurological disorders or mobility impairments may not benefit from this study.
Why it matters
Potential benefit: If successful, this device could provide a valuable non-pharmacological option for managing motor symptoms in patients with Parkinson's Disease.
How similar studies have performed: While the approach of using wearable devices for symptom management is gaining traction, this specific device's usability and acceptability in older adults with Parkinson's Disease is novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1\. Individuals under the care of a Cambridge University Hospitals Foundation Trust movement disorder service with an established clinical diagnosis of Parkinson's disease based on the UK Brain bank criteria Exclusion Criteria: 1. Co-existing significant neurological disorder (disabling stroke, multiple sclerosis, dementia, motor neurone disease), 2. Atypical parkinsonian disorder diagnosis (e.g. multiple systems atrophy, progressive supranuclear palsy or cortical basal degeneration syndrome) 3. co-existing physical impairment or disability causing significant mobility impairment (severe lower limb osteoarthritis) 4. trauma or pain to the sternum 5. use of other medical device e.g. pacemaker, deep brain stimulator, TENS machine etc 6. lacking capacity to consent to the study 7. Sensitivity to medical adhesives 8. Existing participant in intervention research trial
Where this trial is running
Cambridge
- Cambridge University Hospitals Foundation Trust — Cambridge, United Kingdom (Recruiting)
Study contacts
- Study coordinator: Alistair J Mackett, MBBS
- Email: alistair.mackett1@nhs.net
- Phone: 01223 217483
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.